Lilly Research Laboratories, Eli Lilly & Co., Indianapolis, IN, USA.
Appl Spectrosc. 2021 Feb;75(2):216-224. doi: 10.1177/0003702820950318. Epub 2020 Aug 27.
Recently, feed frame-based process analytical technology measurements used to assure product quality during continuous manufacturing processes have received significant attention. These measurements are able to accurately determine uniformity of the powder blend before compression, and in these applications, it is necessary to understand the interrogated sample volume per measurement. This understanding ensures that the blend measurement can be indicative of the uniformity of the final dosage form. A scientifically sound approach is proposed here to estimate sample mass for a continuous manufacturing process that utilizes either near infrared or Raman spectroscopy. A wide range of commercially available probes with varying spot diameters are considered. By comparing near infrared and Raman spectroscopy, an optimal range of probe spot diameters was identified in order to reach an estimated sample mass between 50 and 500 mg for pharmaceutical blends per measurement, which is equivalent to common tablet weight ranges for solid oral dosage forms currently on the market.
最近,基于给料器框架的过程分析技术测量方法在连续制造过程中用于确保产品质量,受到了广泛关注。这些测量方法能够在压缩前准确地确定粉末混合物的均匀性,在这些应用中,有必要了解每次测量的被检测样品体积。这种理解确保了混合测量能够指示最终剂型的均匀性。本文提出了一种科学合理的方法,用于估计使用近红外或拉曼光谱的连续制造过程中的样品质量。考虑了各种具有不同光斑直径的商业上可获得的探头。通过比较近红外和拉曼光谱,确定了最佳的探头光斑直径范围,以便在每次测量时达到 50 至 500mg 的估计样品质量,这相当于当前市场上常用的固体口服剂型的片剂重量范围。